Risk-adapted Therapy

Risk-Adapted Therapy is a treatment strategy in hematologic malignancies that belongs to the class of therapeutic decision frameworks and is distinguished by its systematic modification of chemotherapy intensity and selection based on individual patient risk profiles derived from prognostic factors such as disease biology, genetic markers, and response assessment.

258

Publications

22K

Citations

2.6K

Authors

1K

Institutions

Publications per year

2017–2026

89

Authors

2.6K

  1. HD
    Hartmut Döhner

    Universität Ulm, Germany

    7 publications · 752 citations

    7

    h-index

  2. TE
    Thomas E. Merchant

    St. Jude Children's Research Hospital, United States

    6 publications · 1.1K citations

    6

    h-index

  3. PL
    P. Leif Bergsagel

    Mayo Clinic in Arizona, United States

    5 publications · 1.5K citations

    5

    h-index

  4. SB
    Salut Brunet

    Hospital de Sant Pau, Spain

    5 publications · 598 citations

    5

    h-index

  5. WE
    W. Eiermann

    Krankenhaus vom Roten Kreuz, Germany

    5 publications · 118 citations

    5

    h-index

1–5 of 2.6K

Venues

  1. Journal of Clinical Oncology

    43 publications · 7K citations

    37

    h-index

  2. Blood

    22 publications · 3.3K citations

    18

    h-index

  3. PubMed

    Repository · 15 publications · 746 citations

    12

    h-index

  4. Pediatric Blood & Cancer

    8 publications · 287 citations

    8

    h-index

  5. Blood Advances

    7 publications · 302 citations

    7

    h-index

1–5